BOT 2.63% 39.0¢ botanix pharmaceuticals ltd

Ann: New Canine Pilot Study Supports Further AD Investigation, page-10

  1. 32 Posts.
    lightbulb Created with Sketch. 16
    While this does open the opportunity for animal usage, I think the main point here is that with this new formulation we are back looking at human AD is a use case after the previous fail.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.